favipiravir
Showing 26 - 46 of 46
Covid19 Trial in South Africa, United Kingdom (CST-2: EIDD-2801, CST-2: Placebo, Nitazoxanide)
Recruiting
- Covid19
- CST-2: EIDD-2801
- +6 more
-
Cape Town, South Africa
- +5 more
Aug 9, 2022
Covid19 Trial in Jakarta (Favipiravir, Oseltamivir 75mg)
Unknown status
- Covid19
- Favipiravir
- Oseltamivir 75mg
-
Jakarta, DKI Jakarta, IndonesiaCipto Mangunkusumo National Referral Hospital
Sep 21, 2020
Covid19 Trial in Brazil, Mexico, United States (Favipiravir, Placebo)
Completed
- Covid19
- Favipiravir
- Placebo
-
Pelham, Alabama
- +37 more
Nov 29, 2021
COVID-19 Trial in Russian Federation (Favipiravir, Standard of care)
Completed
- COVID-19
- Favipiravir
- Standard of care
-
Moscow, Russian Federation
- +4 more
Nov 3, 2020
Coronavirus Disease (COVID-19) Trial in Cairo (favipiravir, Standard of care therapy)
Completed
- Coronavirus Disease (COVID-19)
- favipiravir
- Standard of care therapy
-
Cairo, Non-US, EgyptFaculty of Medicine Ain Shams University Research Institute- Cli
Jun 24, 2020
COVID-19, Favipiravir, Kaletra Trial in Tehran (Favipiravir, Hydroxychloroquine, Lopinavir / Ritonavir)
Completed
- COVID-19
- +4 more
- Favipiravir
- +2 more
-
Tehran, Iran, Islamic Republic ofMohammad Sadegh Bagheri Baghdasht
Jun 12, 2020
COVID-19, Favipiravir (Favipira) Trial in Dhaka (Favipiravir, Only Standard Treatment)
Recruiting
- COVID-19
- Favipiravir (Favipira)
- Favipiravir
- Only Standard Treatment
-
Dhaka, BangladeshMahanagar General Hospital, Dhaka (Site-1), Mugda Medical Colleg
May 22, 2020
COVID-19 Trial in Tehran (Favipiravir, Hydroxychloroquine)
Unknown status
- COVID-19
- Favipiravir
- Hydroxychloroquine
-
Tehran, Iran, Islamic Republic ofShahid Modarres Hospital, Shahid Beheshti University of Medical
Apr 26, 2020
COVID-19 Trial in Milano (Favipiravir, Placebo)
Unknown status
- COVID-19
- Favipiravir
- Placebo
-
Milano, ItalyAsst Fatebenefratelli Sacco
Apr 7, 2020
COVID-19 Trial in Beijing, Wuhan (Favipiravir Combined With Tocilizumab, Favipiravir, Tocilizumab)
Unknown status
- COVID-19
- Favipiravir Combined With Tocilizumab
- +2 more
-
Beijing, Beijing, China
- +5 more
Apr 8, 2020
COVID-19 Trial in China (Favipiravir)
Unknown status
- COVID-19
- Favipiravir
-
Fuyang, Anhui, China
- +7 more
Apr 22, 2020
Influenza, Human, Critical Illness, Influenza Trial in Beijing (Favipiravir, Oseltamivir 75Mg Capsule)
Completed
- Influenza, Human
- +2 more
- Favipiravir
- Oseltamivir 75Mg Capsule
-
Beijing, ChinaChina-Japan Friendship Hospital
May 14, 2019
Ebola Virus Survivor Trial in Conakry, Nzérékoré (Favipiravir)
Terminated
- Ebola Virus Survivor
- Favipiravir
-
Conakry, Guinea
- +1 more
Oct 17, 2018
COVID-19 Infection Trial in Worldwide (Plitidepsin, Dexamethasone, Remdesivir)
Recruiting
- COVID-19 Infection
- Plitidepsin
- +3 more
-
La Plata, Buenos Aires, Argentina
- +103 more
Aug 3, 2022
Ebola Virus Disease Trial in Guinea (Favipiravir)
Completed
- Ebola Virus Disease
- Favipiravir
-
Conakry, Guinea
- +3 more
Nov 14, 2016
Ebola Virus Disease Trial (WHO-recommended therapies, Favipiravir)
Completed
- Ebola Virus Disease
- WHO-recommended therapies
- Favipiravir
- (no location specified)
Jan 21, 2016
Healthy, Hepatic Impairment Trial in Miami, Orlando (Favipiravir)
Completed
- Healthy
- Hepatic Impairment
- Favipiravir
-
Miami, Florida
- +1 more
Oct 20, 2015
Influenza Trial in Miami (Placebo, Favipiravir)
Completed
- Influenza
- Placebo
- Favipiravir
-
Miami, FloridaMiami Research Associates
Sep 30, 2015
Influenza Trial in Worldwide (Favipiravir, Placebo comparator)
Completed
- Influenza
- Favipiravir
- Placebo comparator
-
Birmingham, Alabama
- +227 more
Oct 20, 2015
Influenza Trial in Worldwide (favipiravir, Placebo)
Completed
- Influenza
- favipiravir
- Placebo
-
Birmingham, Alabama
- +221 more
Oct 20, 2015
Influenza Trial in Worldwide (favipiravir, )
Completed
- Influenza
- favipiravir
- placebo
-
Birmingham, Alabama
- +246 more
Oct 20, 2015